Log in

OTCMKTS:SBMFFSino Biopharmaceutical Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $1.85
50-Day Range
MA: $1.70
52-Week Range
Now: $1.85
Volume50 shs
Average Volume4,157 shs
Market Capitalization$23.29 billion
P/E RatioN/A
Dividend YieldN/A
Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. The company's principal products also include Analgesic medicines, such as Kaifen injections and Zepusi Flurbiprofen Cataplasms; Orthopedic medicines, which comprise New Ossified Triol capsules and Jiuli tablets; anti-infectious medicines, including Tiance injections and Tianjie tablets; parenteral nutritious medicines, such as Xinhaineng and Fenghaineng fructose injections; respiratory system medicines, including Tianqingsule inhalation powder and Chia Tai Suke tablets; and anorectal medicines comprising Aisuping injections and Getai tablets. In addition, it develops medicines for liver, tumor, cardio-cerebral, analgesia, respiratory system, and orthopedic diseases; engages in the retail and distribution of pharmaceutical products; provides medical management consultancy services; and manufactures, sells, and distributes health food products, as well as is involved in optometry for optical glasses and sale of ophthalmic products. Further, the company provides research and development, medical technology development, and outpatient and surgical procedure services. The company was incorporated in 2000 and is headquartered in Wanchai, Hong Kong.
Read More
Sino Biopharmaceutical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:SBMFF



Sales & Book Value

Annual Sales$3.16 billion
Cash Flow$0.14 per share
Book Value$0.45 per share



Outstanding Shares12,588,300,000
Market Cap$23.29 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive SBMFF News and Ratings via Email

Sign-up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.

Sino Biopharmaceutical (OTCMKTS:SBMFF) Frequently Asked Questions

How has Sino Biopharmaceutical's stock been impacted by COVID-19 (Coronavirus)?

Sino Biopharmaceutical's stock was trading at $1.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SBMFF shares have increased by 28.5% and is now trading at $1.85. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Sino Biopharmaceutical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sino Biopharmaceutical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sino Biopharmaceutical.

Has Sino Biopharmaceutical been receiving favorable news coverage?

News stories about SBMFF stock have been trending negative recently, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sino Biopharmaceutical earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the next few days. View the latest news about Sino Biopharmaceutical.

Who are some of Sino Biopharmaceutical's key competitors?

Who are Sino Biopharmaceutical's key executives?

Sino Biopharmaceutical's management team includes the following people:
  • Ms. Y. Y. Tse, Chairlady (Age 26)
  • Mr. Ping Tse, Founder, CEO & Director (Age 67)
  • Ms. Cheung Ling Cheng, Vice Chairlady (Age 55)
  • Mr. Zhoushan Tian, Exec. Director (Age 55)
  • Mr. Shanchun Wang, Exec. Director & Pres of CT Tianqing (Age 51)

What is Sino Biopharmaceutical's stock symbol?

Sino Biopharmaceutical trades on the OTCMKTS under the ticker symbol "SBMFF."

How do I buy shares of Sino Biopharmaceutical?

Shares of SBMFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sino Biopharmaceutical's stock price today?

One share of SBMFF stock can currently be purchased for approximately $1.85.

How big of a company is Sino Biopharmaceutical?

Sino Biopharmaceutical has a market capitalization of $23.29 billion and generates $3.16 billion in revenue each year. Sino Biopharmaceutical employs 21,498 workers across the globe.

What is Sino Biopharmaceutical's official website?

The official website for Sino Biopharmaceutical is www.sinobiopharm.com.

How can I contact Sino Biopharmaceutical?

Sino Biopharmaceutical's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The company can be reached via phone at 852-2802-9886 or via email at [email protected]

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.